Randomized phase II trial of Gemcitabine and Paclitaxel with or without maintenance treatment in patients with cisplatin refractory transitional cell carcinoma

被引：0
|
作者：
Fechner, GH
Siener, R
Reimann, M
Strunk, R
Golinski, C
Heimbach, D
Wiebusch, H
Langbein, S
Ehlert, C
Bannowsky, A
Heidenreich, A
Kühn, M
Albers, P
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：284 / 284
页数：1
相关论文
共 50 条
  • [21] A randomized phase II trial of durvalumab and tremelIMUmab with gemcitabine or gemcitabine and cisplatin compared to gemcitabine and cisplatin in treatment-naive patients with CHolangio- and gallbladdEr Carcinoma (IMMUCHEC)
    Vogel, A.
    Boeck, S.
    Waidmann, O.
    Bitzer, M.
    Wenzel, P.
    Belle, S.
    Springfeld, C.
    Schulze, K.
    Weinmann, A.
    Lindig, U.
    Trautwein, C.
    Dechow, T.
    Lammert, F.
    Plentz, R.
    Koehne, C-H.
    Kunzmann, V.
    Maenz, M.
    Kirstein, M. M.
    Saborowski, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S563 - S563
  • [22] Randomized phase II trial of gemcitabine/cisplatin (GC) with or without cetuximab (CET) in patients (pts) with advanced urothelial carcinoma (UC).
    Grivas, Petros
    Agarwal, Neeraj
    Siefker-Radtke, Arlene O.
    Daignault, Stephanie
    Puzanov, Igor
    MacVicar, Gary R.
    Levine, Ellis Glenn
    Srinivas, Sandy
    Twardowski, Przemyslaw
    Eisenberger, Mario A.
    Quinn, David I.
    Vaishampayan, Ulka N.
    Yu, Evan Y.
    Dawsey, Scott
    Day, Kathleen C.
    Day, Mark L.
    Smith, David C.
    Hussain, Maha
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Phase II trial of intravesical gemcitabine in bacille Calmette-Guerin-refractory transitional cell carcinoma of the bladder
    Dalbagni, G
    Russo, P
    Bochner, B
    Ben-Porat, L
    Sheinfeld, J
    Sogani, P
    Donat, MS
    Herr, HW
    Bajorin, D
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 2729 - 2734
  • [24] A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus
    Ilson, DH
    Forastiere, A
    Arquette, M
    Costa, F
    Heelan, R
    Huang, Y
    Kelsen, DP
    CANCER JOURNAL, 2000, 6 (05): : 316 - 323
  • [25] Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99)
    Fechner, G
    Siener, R
    Reimann, M
    Kobalz, L
    Albers, P
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (01) : 27 - 31
  • [26] Gemcitabine and paclitaxel regimen for patients with advanced transitional cell carcinoma
    Takahashi, T
    Higashi, S
    Nishiyama, H
    Itoh, N
    Yamamoto, S
    Kamoto, T
    Ogawa, O
    JOURNAL OF UROLOGY, 2005, 173 (04): : 359 - 360
  • [27] A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus
    Zhang, Xiaodong
    Shen, Lin
    Li, Jie
    Li, Yan
    Li, Jian
    Jin, Maolin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 29 - 33
  • [28] Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma - A phase I/II trial of gemcitabine, paclitaxel, and methotrexate
    Lara, PN
    Meyers, FJ
    Law, LY
    Dawson, NA
    Houston, J
    Lauder, I
    Edelman, MJ
    CANCER, 2004, 100 (01) : 82 - 88
  • [29] Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma A Phase 2 Randomized Clinical Trial
    Pal, Sumanta K.
    Frankel, Paul H.
    Mortazavi, Amir
    Milowsky, Matthew
    Vaishampayan, Ulka
    Parikh, Mamta
    Lyou, Yung
    Weng, Peng
    Parikh, Rahul
    Teply, Benjamin
    Dreicer, Robert
    Emamekhoo, Hamid
    Michaelson, Dror
    Hoimes, Christopher
    Zhang, Tian
    Srinivas, Sandy
    Kim, William Y.
    Cui, Yujie
    Newman, Edward
    Lara, Primo N., Jr.
    JAMA ONCOLOGY, 2021, 7 (10) : 1536 - 1543
  • [30] A phase II trial of gemcitabine and carboplatin (GC) in patients with transitional cell carcinoma of the urinary tract (TCC).
    Olivares, J
    Hyman, W
    Senzer, N
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 404S - 404S
12345